ASHLEY MOYER: Open Payments
NPI 1215386065 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 68 payments from 20 companies in 2025. Trend: 2023 $623 · 2024 $432 · 2025 $1,619
Food & beverage: $1,619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $278 |
| AstraZeneca Pharmaceuticals LP | 7 | $237 |
| Novo Nordisk Inc | 8 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $152 |
| ViiV Healthcare Company | 1 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
Products named: QULIPTA, BREZTRI, Ozempic, CAPLYTA, APRETUDE, Kerendia, FANAPT, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
